| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 28 | 32 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 2.269 | 1.612 | 1.621 | 1.936 | 673 | 794 | 538 | 424 | 305 | 271 |
| Gross Profit/Loss - EUR | -2.269 | -1.612 | -1.621 | -1.908 | -641 | -794 | -538 | -424 | -305 | -271 |
| Net Profit/Loss - EUR | -2.269 | -1.612 | -1.621 | -1.908 | -641 | -794 | -538 | -424 | -305 | -271 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medramol Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.604 | 1.146 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 8.822 | 7.938 | 7.418 | 4.719 | 3.008 | 2.157 | 1.551 | 1.152 | 1.859 | 1.577 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.111 | 1.090 | 1.072 | 1.052 | 1.032 | 1.012 | 990 | 993 | 990 | 984 |
| Cash | 7.711 | 6.848 | 6.346 | 3.667 | 1.976 | 1.145 | 561 | 159 | 869 | 593 |
| Shareholders Funds | 8.046 | 6.352 | 4.623 | 2.652 | 1.960 | 1.129 | 566 | 143 | -162 | -432 |
| Social Capital | 22.497 | 22.268 | 21.891 | 21.511 | 21.094 | 20.694 | 20.235 | 20.298 | 20.237 | 20.123 |
| Debts | 2.401 | 2.737 | 2.800 | 2.072 | 1.053 | 1.033 | 990 | 1.013 | 2.021 | 2.010 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
6622
|
|||||||||
Comments - Medramol Srl